Company Overview and News
Sydney, 5 April 2018: Cooper Basin focused oil & gas exploration company, Real Energy Corporation Limited (ASX: RLE) (“Real Energy”) advises that Tamarama-2 wellsite has been prepared and is ready for drilling operations.
Sydney: 3 October, 2017, Cooper Basin focused oil & gas exploration company, Real Energy Corporation Limited (ASX: RLE), is pleased to announce that it has raised $2.34 million through the issue of approximately 26 million new fully paid ordinary shares at $0.09 per share. The issue was heavily oversubscribed.
Real Energy Corporation Ltd (ASX:RLE) has raised $2.34 million via an oversubscribed share placement to existing and new shareholders at $0.09 per share.
Cooper Basin focused oil & gas exploration company, Real Energy Corporation Limited (ASX:RLE) (“Real Energy ”), advises that following test work undertaken in the last two weeks, the Tamarama-1 well is currently shut in ahead of further operations. Real Energy has completed a series of further tests ahead of shutting in the well to build up pressure. During this phase of test work, gas and fluids have continued to flow from the well.
Cooper Basin focused oil and gas exploration company, Real Energy Corporation Limited, has announced that the company is witnessing a significant increase in gas flows and frack fluids rates from the Tamarama-1 well as additional fracture stimulated zones progressively come in.
Cooper Basin focused oil & gas exploration company, Real Energy Corporation Limited (ASX:RLE), advises that the Company is witnessing a significant increase in gas flows and frac fluids rates from the Tamarama-1 well as additional fracture stimulated zones progressively come in. It is estimated that as at 7.00 am EST on 17 August 2016, approximately 3,500 barrels (or over 40%) of frac fluid have been recovered so far from the well.
Cooper Basin focused oil & gas exploration company, Real Energy Corporation Limited (ASX:RLE), advises that the Company has successfully concluded the re-completion operations at Tamarama-1 well. The latest intervention involved removal of the existing tubing, and re-entering the lower diversion assemblies with a small drill to mechanically remove the blockage in the tubing string. The well has now completed with a production tubing string and the post-frac flow back operation has resumed.
Cooper Basin focused oil & gas exploration company, Real Energy Corporation Limited, has announced that it has successfully concluded the re-completion operations at Tamarama-1 well.
Cooper Basin focused oil & gas exploration company, Real Energy Corporation Limited (ASX:RLE), advises that the Company has recommenced field operations. The wireline correlation run has confirmed that the stuck isolating ball will be required to be removed by the workover rig operations. The Company scheduled a workover rig to the site at the end of July to remove the frac string so we can commence the flow testing.
Cooper Basin focused oil & gas exploration company, Real Energy Corporation Limited (ASX:RLE), is pleased to advise that following completion of the five stage Fracture Stimulation program at Tamarama-1, the well has unloaded some frac fluids and sands. Real Energy has now decided to mobilise a coiled tubing unit which will speed up the clean up of the wellbore in order to move into the flow testing phase as soon as possible.
Real Energy Corporation Ltd (ASX:RLE) is an oil and gas exploration and development company with a focus on the Cooper basin, Australia’s most prolific conventional onshore petroleum producing basin.
Cooper Basin focused oil and gas company, Real Energy Corporation Limited has commenced a five-stage fracture stimulation program at the Tamarama-1 well at located in the Windorah Gas Project in ATP 927P, Australia, Queensland.
2018-04-23 - Asif
Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...